Fluorescence in situ hybridization analysis using PAX8- and PPARG-specific probes reveals the presence of PAX8-PPARG translocation and 3p25 aneusomy in follicular thyroid neoplasms

Cancer Genetics and Cytogenetics

Volumn 196, Issue 1, 2010, Pages 7-13

  Chia, Wai Kit ^a   Sharifah, Noor Akmal ^a   Reena, Rahayu Md Zin ^a   Zubaidah, Zakaria ^b   Clarence Ko, Ching Huat ^a   Rohaizak, Muhammad ^a   Naqiyah, Ibrahim ^a   Srijit, Das ^a   Hisham, Abdullah Nor ^c   Asmiati, Arbi ^c   Rafie, Md Kaslan ^c  

^a UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

^b INSTITUTE FOR MEDICAL RESEARCH   (Malaysia)

^c PUTRAJAYA HOSPITAL   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSCRIPTION FACTOR PAX8;

ARTICLE; CHROMOSOME 3P; CONTROLLED STUDY; ETHNICITY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE ACTIVITY; GENE FREQUENCY; GENE FUNCTION; GENE PROBE; GENE TRANSLOCATION; GENETIC ANALYSIS; GEOGRAPHY; HUMAN; HUMAN TISSUE; MALE; ONCOCYTOMA; PRIORITY JOURNAL; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA;

CHROMOSOME ABERRATIONS; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CHROMOSOMES, HUMAN, PAIR 3; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MOLECULAR PROBES; PAIRED BOX TRANSCRIPTION FACTORS; PPAR GAMMA; THYROID NEOPLASMS; TRANSLOCATION, GENETIC;

EID: 71149106901     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.08.001     Document Type: Article

References (37)

1. Abdullah M. Thyroid cancer: the Kuala Lumpur experience. ANZ J Surg 72 (2002) 660-664
2. Voralu K., Norsa'adah B., Naing N.N., and Biswal B.M. Prognostic factors of differentiated thyroid cancer patients in Hospital Universiti Sains Malaysia. Singapore Med J 47 (2006) 688-692
3. Gharib H. Changing concepts in the diagnosis and management of thyroid nodules. Endocrinology and Metabolism Clinics of North America 26 (1997) 777-800
4. Mitelman F. Recurrent chromosome aberrations in cancer. Mutat Res 462 (2000) 247-253
5. Huettner C.S.S., Zhang P., Van Etten R.A., and Tenen D.G. Reversibility of acute B-cell leukemia induced by BCR-ABL1. Nat Genet 24 (2000) 57-60
6. Druker B.J., Sawyers C.L., Kantarjian H., Resta D.J., Reese S.F., Ford J.M., Capdeville R., and Talpaz M. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med 344 (2001) 1038-1042
7. Kroll T.G., Sarraf P., Pecciarini L., Chen C.J., Elisabetta M., Spiegelman B.M., and Fletcher J.A. PAX8-PPARγ1 fusion oncogene in human thyroid carcinoma. Science 289 (2000) 1357-1360
8. French C.A., Alexander E.K., Cibas E.S., Nose V., Laguette J., Faquin W., Garber J., Moore Jr. F., Fletcher J.A., Larsen P.R., and Kroll T.G. Genetic and biological subgroups of low-stage follicular thyroid cancer. Am J Pathol 162 (2003) 1053-1060
9. Lui W.O., Foukakis T., Liden J., Thoppe S.R., Dwight T., Hoog A., Zedenius J., Wallin G., Reimers M., and Larsson C. Expression profiling reveals a distinct transcription signature in follicular thyroid carcinomas with a PAX8-PPAR γ fusion oncogene. Oncogene (2004) 1-10
10. Alcaraz A., Takahashi S., Brown J.A., Herath J.F., Bergstralh E.J., Larson-Keller J.J., Lieber M.M., and Jenkins R.B. Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer. Cancer Res 54 (1994) 3998-4002
11. Takahashi S., Alcaraz A., Brown J.A., Borell T.J., Herath J.F., Bergstralh E.J., Lieber M.M., and Jenkins R.B. Aneusomies of chromosomes 8 and Y detected by fluorescence in situ hybridization are prognostic markers for pathological stage C (pT3NoM o) prostate carcinoma. Clin Cancer Res 2 (1996) 137-145
12. Wang S., Saboorian M.H., Frenkel E.P., Haley B.B., Siddiqui M.T., Gokaslan S., Hynan L., and Ashfaq R. Aneusomy 17 in breast cancer: its role in HER-2/neu protein expression and implication for clinical assessment of HER-2/neu status. Mod Pathol 15 (2002) 137-145
13. Nakamura H., Saji H., Idiris A., Kawasaki N., Hosaka M., Ogata A., Saijo T., and Kato H. Chromosomal instability detected by fluorescence in situ hybridization in surgical specimens of non-small cell lung cancer is associated with poor survival. Clin Cancer Res 9 (2003) 2294-2299
14. Hopman A.H.N., Kamps M.A.F., Speel E.J.M., Schapers R.F.M., Sauter G., and Ramaekers F.C.S. Identification of chromosome 9 alterations and p53 accumulation in isolated carcinoma in situ of the urinary bladder versus carcinoma in situ associated with carcinoma. Am J Pathol 161 (2002) 1119-1125
15. Wolman S.R., Goldman B., Slovak M.L., Tangen C., Persons D.L., and Wood D. Aneusomy for detection of bladder cancer recurrence: a Southwest Oncology Group study. Cancer Genet Cytogenet 176 (2007) 22-27
16. Carlson J.A., Healy K., Tran T.A., Malfetano J., Wilson V.L., Rohwedder A., and Ross J.S. Chromosome 17 aneusomy detected by fluorescence in situ hybridization in vulvar squamous cell carcinomas and synchronous vulvar skin. Am J Pathol 157 (2000) 973-983
17. Isaka T., Nestor A.L., Takada T., and Allison D.C. Chromosomal variations within aneuploid cancer lines. J Histochem Cytochem 51 (2003) 1343-1353
18. Mendelin J., Grayson M., Wallis T., and Visscher D. Analysis of chromosome aneuploidy in breast carcinoma progression by using fluorescence in situ hybridization. Lab Invest 79 (1999) 387-393
19. Kontogeorgos G. The art and applications of fluorescence in situ hybridization in endocrine pathology. Endocrine Pathology 11 (2000) 123-136
20. Aubele M., Mattis A., Zitzelsberger H., Walch A., Kremer M., Hutzler P., Hofler H., and Werner M. Intratumoral heterogeneity in breast carcinoma revealed by laser - microdissection and comparative genomic hybridization. Cancer Genet Cytogenet 110 (1999) 94-102
21. Schmitt F.C., Longatto-Filho A., Valent A., and Vielh P. Molecular techniques in cytopathology practice. J. Clin. Pathol 61 (2008) 258-267
22. Nikiforova M.N., Biddinger P.W., Caudill C.M., Kroll T.G., and Nikiforov Y.E. PAX8-PPAR gamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses. Am J Surg Pathol 26 (2002) 1016-1023
23. Hibi Y., Nagaya T., Kambe F., Imai T., Funahashi H., Nakao A., and Seo H. Is thyroid follicular cancer in Japanese caused by a specific t(2;3)(q13;p25) translocation generating Pax8-PPARγ fusion mRNA?. Endocrine Journal 51 (2004) 361-366
24. Kitamura Y., Shimizu K., Ito K., Tanaka S., and Emi M. Allelotyping of follicular thyroid carcinoma: frequent allelic losses in chromosome arms 7q, 11p and 22q. J Clin Endocrinol Metab 86 (2001) 4268-4272
25. Criado B., Barros A., Suijkerbuijk R.F., Weghuis D.O., Seruca R., Fonseca E., and Castedo S. Detection of numerical alterations for chromosomes 7 and 12 in benign thyroid lesions by in situ hybridization. Am J Pathol 147 (1995) 136-144
26. Barril N., Carvalho-Sales A.B., and Tajara E.H. Detection of numerical chromosome anomalies in interphase cells of benign and malignant thyroid lesions using fluorescence in situ hybridization. Cancer Genet Cytogenet 117 (2000) 50-56
27. Jenkins R.B., Hay I.D., Herath J.F., Schultz C.G., Spurbeck J.L., Grant C.S., Goellner J.R., and Dewald G.W. Frequent occurrence of cytogenetic abnormalities in sporadic nonmedullary thyroid carcinoma. Cancer 66 (1990) 1213-1220
28. Roque L., Castedo S., Clode A., and Soares J. Deletion of 3p25→pter in a primary follicular thyroid carcinoma and its metastasis. Genes Chromosomes Cancer 8 (1993) 199-203
29. Zedenius J., Wallin G., Svensson A., Grimelius L., Hoog A., Lundell G., Backdahl M., and Larsson C. Allelotyping of follicular thyroid tumors. Hum Genet 96 (1995) 27-32
30. Maximo V., Soares P., Lima J., Cameselle-Teijeiro J., and Sobrinho-Simoes M. Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hurthle cell tumors. Am J Pathol 160 (2002) 1857-1865
31. Marques A.R., Espadinha C., Catarino A.L., Moniz S., Pereira T., Sobrinho L.G., and Leite V. Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas. J Clin Endocrinol Metab 87 (2002) 3947-3952
32. Cheung L., Messina M., Gill A., Clarkson A., Learoyd D., Delbridge L., Wentworth J., Philips J., Clifton-Bligh R., and Robinson B.G. Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas. J Clin Endocrinol Metab 88 (2003) 354-357
33. Zhu Z., Gandhi M., Nikiforova M.N., Fischer A.H., and Nikiforov Y.E. Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations. Am J Clin Pathol 120 (2003) 71-77
34. Nikiforova M.N., Lynch R.A., Biddinger P.W., Alexander E.K., Dorn II G.W., Tallini G., Kroll T.G., and Nikiforov Y.E. RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab 88 (2003) 2318-2326
35. Dwight T., Thoppe S.R., Foukakis T., Lui W.O., Wallin G., Hoog A., Frisk T., Larsson C., and Zedenius J. Involvement of the PAX8/peroxisome proliferator-activated receptor γ rearrangement in follicular thyroid tumors. J Clin Endocrinol Metab 88 (2003) 4440-4445
36. Castro P., Roque L., Magalhaes J., and Sobrinho-Simoes M. A subset of the follicular variant of papillary thyroid carcinoma harbors the PAX8-PPARgamma translocation. Int J Surg Pathol 13 (2005) 235-238
37. Sahin M., Allard B.L., Yates M., Gregory Powell J., Wang X.-L., Hay I.D., Zhao Y., Goellner J.R., Sebo T.J., Grebe S.K.G., Eberhardt N.L., and McIver B. PPAR γ staining as a surrogate for PAX8/PPARγ fusion oncogene expression in follicular neoplasms: clinicopathological correlation and histopathological diagnostic value. J Clin Endocrinol Metab 90 (2005) 463-468